G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer
- Kaitlyn J. Andreano
- , Suzanne E. Wardell
- , Jennifer G. Baker
- , Taylor K. Desautels
- , Robert Baldi
- , Christina A. Chao
- , Kendall A. Heetderks
- , Yeeun Bae
- , Rui Xiong
- , Debra A. Tonetti
- , Lauren M. Gutgesell
- , Jiong Zhao
- , Jessica A. Sorrentino
- , Delita A. Thompson
- , John E. Bisi
- , Jay C. Strum
- , Gregory R.J. Thatcher
- , John D. Norris
Research output: Contribution to journal › Article › peer-review
44
Link opens in a new tab
Scopus
citations